【レポートの概要（一部）】
1. Report Overview
1.1 The Alzheimer’s Disease Therapeutics and Diagnostics Market Overview
1.2 The Alzheimer’s Disease Therapeutics and Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Alzheimer’s Disease: An Introduction
2.1 Neurodegenerative Diseases
2.1.1 What is Alzheimer’s Disease?
2.1.2 What Causes Alzheimer’s Disease?
2.1.2.1 Alzheimer’s Disease: Type 3 Diabetes?
2.1.3 Management of Alzheimer’s Disease
2.1.4 The Socio-Economic Impact of Alzheimer’s Disease
2.1.5 Diagnosis of Alzheimer’s Disease
3. Alzheimer’s Disease Therapeutics and Diagnostics Market 2016-2026
3.1 Alzheimer’s Disease Therapeutics and Diagnostics Market, 2015
3.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
3.2.1 The Market Has Been Left Exposed to Intensified Generic Competition
3.2.2 Healthcare Costs for Alzheimer’s Disease Will Surpass All Other Medical Expenses
3.2.3 New Diagnostics and Drugs Regulatory Guidelines Will Lower the Barriers to Entry
3.3 Drivers and Restraints
4. The Alzheimer’s Disease Drugs Market, 2016-2026
4.1 Current Approaches and Unmet Needs in the Treatment of Alzheimer’s disease
4.2 The Alzheimer’s Disease Drugs Market, 2015
4.3 Changing Market Shares of the Leading Alzheimer’s Disease Drugs, 2016-2026
4.4 The Alzheimer’s Disease Drugs Market Forecast 2016-2026
4.5 Namenda
4.5.1 Namenda Sales Forecast, 2016-2026
4.6 Aricept
4.6.1 Aricept Sales Forecast, 2016-2026
4.7 Exelon
4.7.1 Exelon Sales Forecast, 2016-2026
4.8 Alzheimer’s Disease Drugs Pipeline, 2015
4.8.1 New Guidelines: FDA to Relax Rules for the Approval of Alzheimer’s Drugs
4.8.2 Will Novel Drug Development Strategies Prove Successful?
4.8.3 Solanezumab (Eli Lilly)
4.8.3.1 Solanezumab Sales Forecast 2016-2026
4.8.4 Gantenerumab (Roche)
4.8.4.1 Gantenerumab Pipeline Forecast, 2015-2026
4.8.5 MK-8931 (Merck)
4.8.5.1 The MK-8931 Pipeline Forecast, 2015-2026
4.8.6 Lu AE58054 (Lundbeck)
4.8.7 TTP488 (TransTechPharma)
4.8.8 LMTX (TauRx)
4.8.9 EVP-6124 (Forum Pharmaceuticals)
4.8.10 Axona (Accera)
4.8.11 AD-4833 (Takeda Pharmaceuticals)
4.9 Deep Brain Stimulation (Functional Neuromodulation)
4.10 Recent Research on Alzheimer’s Disease
5. Leading Companies in the Alzheimer’s Disease Drugs Market, 2015
5.1 Pfizer, Inc
5.1.1 Sales and Recent Performance Analysis, 2015
5.1.2 Pfizer: Aricept
5.1.3 Pfizer: R&D Capabilities and Alzheimer’s Disease Drug Candidates
5.2 Eisai
5.2.1 Sales and Recent Performance Analysis, 2015
5.2.2 Eisai: Aricept
5.2.3 Eisai: R&D Capabilities and Alzheimer’s Disease Drug Candidates
5.2.4 Collaboration with Biogen
5.2.5 Partnership with GE Healthcare for Diagnostic Development
5.3 Forest Laboratories (Acquired by Actavis)
5.3.1 Acquisition by Actavis
5.3.2 Forest: Namenda
5.3.3 Namenda’s Sales and Recent Performance Analysis, 2014
5.4 Lundbeck A/S
5.4.1 Sales and Recent Performance Analysis, 2014
5.4.2 Lundbeck: R&D Capabilities
5.4.3 Lundbeck’s Alzheimer’s Disease Drug Pipeline
5.4.4 Lundbeck: Ebixa
5.5 Daiichi Sankyo
5.5.1 Financial Sales and Recent Performance, 2015
5.5.2 Daiichi Sankyo: Memary
5.6 Novartis AG
5.6.1 Sales and Recent Performance Analysis
5.6.2 Novartis: Exelon
5.6.3 eHealth Programme Delivering Innovation
5.6.4 Novartis: Alzheimer’s Disease Drug Pipeline
5.7 TauRx
5.7.1 Partnership with Bayer Schering Pharma AG
5.8 vTv Therapeutics
5.8.1 TTP Translational Technology
5.8.2 vTv Therapeutics: Alzheimer’s Disease Pipeline Portfolio
6. The Alzheimer’s Disease Diagnostics Market, 2015-2026
6.1 There is Still a Strong Market Need for Effective Diagnosis
6.2 The Alzheimer’s Disease Diagnostics Market, 2015
6.3 Changing Market Shares of Leading Alzheimer’s Diagnostic Markets, 2015-2026
6.4 The Alzheimer’s Diagnostics Market, 2015-2026
6.5 New Criteria and Guidelines to Diagnose Alzheimer’s Disease
6.6 Biomarkers for Alzheimer’s Disease
6.6.1 Leading Companies Pursuing Novel Biomarker Development Strategies
6.7 Alzheimer’s Disease: Advances in Diagnostic Imaging Technologies
6.7.1 Structural Imaging
6.7.2 Functional Imaging
6.7.3 Molecular Imaging Technologies
6.7.3.1 Pittsburgh Compound B (PIB) (GE Healthcare)
6.7.3.2 Florbetapir F18 (18F-AV-45) (Eli Lilly)
6.7.3.3 Flutemetamol (GE Healthcare)
6.7.3.4 Florbetaben (Piramal Imaging)
6.8 Other Alzheimer’s Diagnostics in Development
6.8.1 CSF Proteins
6.8.2 Blood Based Biomarkers for Alzheimer’s Disease
6.8.3 Genetic Risk Profiling
6.8.4 Eye Tests
6.8.5 Nanoparticles
6.9 Leading Companies in the Alzheimer’s Disease Diagnostics Market, 2015
6.9.1 Eli Lilly
6.9.1.1 Recent Performance and Sales Analysis, 2015
6.9.1.2 Alzheimer’s Disease Research Effort
6.9.1.3 Solanezumab
6.9.1.4 Amyvid (Florbetapir F18)
6.9.1.5 Amyvid Receives Marketing Authorization from the European Commission
6.9.1.6 LY-2886721: Terminated Drug
6.9.1.7 LY3002813: Phase I
6.9.1.8 Eli Lilly Acquires Novel Tau Tangle Diagnostic Programme
6.9.2 Amarantus BioScience Holdings, Inc.
6.9.2.1 Recent Performance and Sales Analysis, 2014
6.9.2.2 LymPro
6.9.2.3 Intellectual Property Acquisitions
6.9.3 Piramal Enterprises
6.9.3.1 Piramal Imaging SA
6.9.3.2 U.S. and EMA Approval of Florbetaben
6.9.3.3 Manufacturing and Distribution Agreements
6.9.4 GE Healthcare
6.9.4.1 GE’s Commitment to Imaging Research in the Alzheimer’s Field
6.9.4.2 Regulatory Approval of Flutemetamol
6.9.4.3 Licensing Agreements for Flutemetamol
6.9.5 Navidea
6.9.5.1 NAV4694 (Fluorine-18)
6.9.5.2 Collaboration Agreements
6.9.5.3 NAV4694 Clinical Development
6.9.6 DiaGenic
7. The Leading National Markets, 2015-2026
7.1 Regional Breakdown of the Global Alzheimer’s Disease Therapeutics and Diagnostic Market, 2015
7.1.1 The US, Japan and Europe Represent More than 80% of the Total Market
7.2 The Global Alzheimer’s Disease Therapeutics and Diagnostics Market: Regional Forecast, 2015-2026
7.3 Changing Market Shares of Leading National Markets 2015-2026
7.4 The US Alzheimer’s Disease Therapeutics and Diagnostics Market, 2015-2026
7.4.1 One in Nine Over the Age of 65 has AD in the US
7.4.2 The US Will Remain the Largest Market Over the Forecast Period
7.5 The European Alzheimer’s Disease Therapeutics and Diagnostics Market, 2015-2026
7.5.1 The German Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.2 The French Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.3 The UK Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.4 The Spanish Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.5 The Italian Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.6 The Rest of Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.6 The Japanese Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.7 The Chinese Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.8 The Indian Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.9 The Brazilian Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.10 The Russian Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.11 The Rest of the World Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
8. Qualitative Analysis of the Alzheimer’s Disease: Therapeutics and Diagnostics Market, 2016-2026
8.1 SWOT Analysis
8.2 Strengths
8.2.1 Alzheimer’s Disease is a High Profile Disease
8.2.2 Expanding Patient Population
8.2.3 Strong R&D Pipeline in Both Sectors of the Market
8.3 Weaknesses
8.3.1 Current Drugs Only Treat the Symptoms of Alzheimer’s Disease
8.3.2 Recent Failures of Promising Drug Candidates in Clinical Trials
8.3.3 Poor Macroeconomic Conditions in Key Regions of the Market
8.4. Opportunities
8.4.1 Regulations Seeking Improved Standards of Alzheimer’s Disease Drug Development
8.4.2 Neurodegenerative Diseases Have Strong R&D
8.4.3 Emerging Markets Will Help Drive the Market
8.4.4 Advances in Diagnostic Technologies Will Improve Drug Market Penetration
8.5 Threats
8.5.1 Patent Expiries Will Lead to Further Generic Competition
8.5.2 New AD Therapies Face Political, Commercial and Social Pressures
8.6 Porter’s Five Force Analysis
8.6.1 Rivalry Among Competitors
8.6.2 Threats of New Entrants
8.6.3 Powers of Suppliers
8.6.4 Bargaining Power of Buyers
8.6.5 Threat of Substitutes
9. Research Interviews from Our Survey
9.1 Mr. Timothy Earle, Chief Operating Officer / Chief Business Officer, TauRx Pharmaceuticals Ltd
9.1.1 Alzheimer’s Treatment in Late Stage Development
9.1.2 Alzheimer’s Severe Under diagnosis
9.1.3 The Benefits of Alzheimer’s Diagnosis: A Future Prospect
9.1.4 Alzheimer’s Treatment: The Greatest Challenge
9.2 Kevin Hrusovsky, Executive Chairman and CEO, Quanterix
9.2.1 Ultra Sensitive Automated Immunoassay Platform for Alzheimer’s
9.2.2 Alzheimer’s Disease Diagnosis Biomarkers
9.2.3 Quanterix: Future Developments
9.3 The Alzheimer’s Association Northern California and Northern Nevada
9.3.1 Alzheimer’s Treatment in Late Stage Development
9.3.2 Novel Biomarkers: Critical for Alzheimer’s Diagnosis
9.3.3 A Push to Improve the Success of Alzheimer’s Research
10. Conclusion
10.1 Novel Diagnostic Technologies Will Emerge First and Then the Disease Modifying Drugs
10.2 Disease Modifying Drugs Will Transform the Declining Alzheimer’s Market
10.3 Demographics Will Help Drive the Market Over the Forecast Period
10.4 Medicines and Diagnostic Tests for Alzheimer’s Disease Hold Great Potential from 2015 to 2026
10.5 Research for Alzheimer’s Happening all Over the World
【レポート販売概要】
■ タイトル：アルツハイマー病治療・診断の世界市場予測2016-2026■ 英文：Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast 2016-2026
■ 発行日：2016年5月
■ 調査会社：visiongain
■ 商品コード：VGAIN60625
■ 調査対象地域：グローバル
- 不正検知・不正防止ソリューションの世界市場予測（～2021年）The Fraud Detection and Prevention Market size is expected to grow from USD 14.36 Billion in 2016 to USD 33.19 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 18.2% during the forecast period. The major growth drivers of the FDP market include the rise in online businesses and electronic transactions, rapid increase in mobile banking, and emergence of big data analytics. The Fraud Dete …
- 殺生物剤の世界市場：ハロゲン化合物、金属化合物、有機硫黄化合物、有機酸、フェノール類Biocides are substances used to kill or inhibit all life forms when introduced in sufficient concentration and duration. Biocides are mostly used to kill harmful organisms and control bacterial or fungal growth. The biocides market is projected to register a CAGR of 4.8% between 2015 and 2020 to reach USD 10.6 billion, by 2020. Water treatment segment is estimated to be the largest application of …
- TurkeyのLead Oxides, Red Lead and Orange Lead市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Turkey and its perspectives on the global market for lead oxides, red lead and orange lead. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on lead oxides, red lead and orange lead export/import operations in Turk …
- 蛋白質成分の世界市場：動物性蛋白質、植物性蛋白質About Protein Ingredients Protein ingredients are protein-rich materials used as ingredients in food, beverages, and feed products such as dietary supplements, sports nutrition products, bakery products, dairy products, ready meals, infant formula, and desserts. They are rich in nutrients with the correct amount of amino acids, and they provide essential nutrients to humans and animals. They are a …
- イタリアの癌診断・検査市場2014This report provides an overview of the Italian cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Table of ContentsBusiness EnvironmentMarket StructureMarket Size, Growth, and Major Suppliers' Market SharesList of TablesTest Volume Forecasts by Market Segment …
- 産業用イーサネットの世界市場2016-2020About Ethernet Ethernet is widely used in office and office networks for data transfers. In recent times, it has entered into factory floor to meet the communication needs of industrial applications. The use of standard Ethernet in an industrial environment is called industrial Ethernet. The environment inside industrial plants is harsh with extreme temperature conditions, humidity, and vibration. …
- IoT IAM（識別およびアクセス管理）の世界市場予測（～2021）：ソリューション別、サービス別、セキュリティ種類別（ネットワークセキュリティ、エンドポイントセキュリティ、アプリケーションセキュリティ、クラウドセキュリティ）、導入モード別、企業規模別、産業別、地域別The Internet of Things (IoT) Identity Access Management (IAM) market size is expected to grow from USD 1.10 Billion in 2016 to USD 4.97 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 35.2% during the forecast period. The major growth drivers of the IoT IAM market include the rise in adoption of Bring Your Own Device (BYOD) trend, rise in frequency of cybersecurity breaches and cyber-a …
- Calvalley Petroleum Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Calvalley Petroleum Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Calvalley Petroleum Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- ANCA血管炎(Anca Vasculitis)：治療薬開発パイプライン動向（2015年上半期版）Anca Vasculitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Anca Vasculitis - Pipeline Review, H1 2015’, provides an overview of the Anca Vasculitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anca Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of acti …
- 梅毒検査の世界市場2015The report presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- 超音波洗浄機の世界市場2017-2021About Ultrasonic Cleaning EquipmentUltrasonic cleaning uses ultrasound and an appropriate cleaning solvent to clean items. The water or appropriate solvent used depends on the type of objects being cleaned, where it usually takes between 3-20 minutes. Ultrasonic cleaning is a method used to clean objects such as jewelry, watches, dental and surgical instruments, tools, lenses and other optical par …
- 世界の半導体（シリコン）IPコア市場動向及び予測(2013 – 2020)Today’s System-on-Chips and advanced ICs integrate a great variety of advanced functionality into a single device to offer superior performance, with more IP cores on a single chip. The rapidly growing consumer applications demand extensively integrated functionality and competitive features, such as optimization between performance and power consumption, all at an aggressive price point. As new p …
- 硫酸マグネシウム七水和物の世界市場Magnesium Sulfate Heptahydrate (CAS 10034-99-8) Market Research Report 2014 presents comprehensive data on magnesium sulfate heptahydrate markets globally and regionally (Europe, Asia, North America etc.) The report includes magnesium sulfate heptahydrate description, covers its application areas and related patterns. It overviews magnesium sulfate heptahydrate market, names magnesium sulfate hept …
- BaaS（サービスとしてのバックアップ）の世界市場2018-2022About Backup-as-a-Service Online backup service, also known as BaaS, refers to the frequent backup of folders, files, or the entire content of HDDs by service providers to remote secure cloud-based data repositories. Technavio’s analysts forecast the Global Backup-as-a-Service Market to grow at a CAGR of 27.04% during the period 2018-2022. Covered in this report The report covers the present scena …
- 産業用歯車モータ及びドライブの世界市場：標準歯車、精密歯車About Industrial Gear Motors and Drives Industrial gear motors and drives are power transmission components that help reduce the complexity and cost of designing and constructing power tools, machines, and appliances that need high torque at relatively low shaft speed. They can be classified into two product segments: Standard Geared Products and Precision Geared Products. TechNavio's analysts for …
